Ipilimumab

Results: 93



#Item
1Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664

Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664

Add to Reading List

Source URL: www.takara-bio.co.jp

Language: English - Date: 2017-06-02 05:25:57
    2Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano

    Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano

    Add to Reading List

    Source URL: www.takara-bio.co.jp

    Language: English - Date: 2016-10-24 01:27:48
      3HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY. YERVOY® (ipilimumab) injection, for int

      HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY. YERVOY® (ipilimumab) injection, for int

      Add to Reading List

      Source URL: packageinserts.bms.com

      - Date: 2016-10-05 16:29:58
        4Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile.  Photo courtesy of Dina Potter. Sunny Tree. 48

        Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48" × 60".

        Add to Reading List

        Source URL: moffitt.org

        Language: English - Date: 2016-03-02 10:23:54
        5Frågeformulär för sjuksköterska  Patientdata Triageguide för Immunrelaterade biverkningar av Ipilimumab: Kryssa i de frågor som du frågat om.

        Frågeformulär för sjuksköterska Patientdata Triageguide för Immunrelaterade biverkningar av Ipilimumab: Kryssa i de frågor som du frågat om.

        Add to Reading List

        Source URL: www.cancercentrum.se

        Language: Swedish - Date: 2012-12-14 03:26:28
          6Sid 1/3  Ipilimumab Ipilimumab (Yervoy)  3 mg/kg

          Sid 1/3 Ipilimumab Ipilimumab (Yervoy) 3 mg/kg

          Add to Reading List

          Source URL: www.cancercentrum.se

          Language: Swedish - Date: 2014-04-11 02:42:53
            7Ipilimumab (Yervoy) for small cell lung cancer – first line, in combination with etoposide and platinum therapy

            Ipilimumab (Yervoy) for small cell lung cancer – first line, in combination with etoposide and platinum therapy

            Add to Reading List

            Source URL: www.hsc.nihr.ac.uk

            Language: English
              8Predictors of Survival: MSKCC Data Base*

              Predictors of Survival: MSKCC Data Base*

              Add to Reading List

              Source URL: www.euikcs.com

              Language: English - Date: 2014-05-13 14:32:18
              9Award ID: DP150099 Project Title: Immunotherapy targeting triple negative breast cancer using NY-ESO-1specific TCRs and blockade of immune suppression Award Mechanism: Bridging the Gap: Early Translational Research Award

              Award ID: DP150099 Project Title: Immunotherapy targeting triple negative breast cancer using NY-ESO-1specific TCRs and blockade of immune suppression Award Mechanism: Bridging the Gap: Early Translational Research Award

              Add to Reading List

              Source URL: www.cprit.state.tx.us

              Language: English - Date: 2014-11-20 01:49:44
              10Bristol-Myers Squibb 2014 Anuual Report

              Bristol-Myers Squibb 2014 Anuual Report

              Add to Reading List

              Source URL: www.bms.it

              Language: English - Date: 2015-03-30 05:25:59